Mobidiag, A Hologic Company

Mobidiag Ltd. develops and provides innovative solutions for in vitro diagnostics (IVD) of infectious diseases, with a high focus on gastrointestinal infections (e.g. gastroenteritis). Mobidiag’s products bring molecular diagnostics to a new era, where improved diagnostics is accessible and affordable. With the Amplidiag® assays, Mobidiag offers diagnostic tests targeting gastrointestinal pathogens and antibiotic resistance directly from stool samples. Amplidiag® utilizes well-established multiplexed real-time PCR technology for fast, robust and reliable results. Established in 2000, Mobidiag has served the European clinical diagnostics market since 2008. In 2013, Mobidiag merged with a diagnostic platform developer Genewave and a stool-based clinical assay development company Amplidiag, complementing our capabilities in developing and offering industry-leading diagnostic solutions and solidifying our position in the field of molecular diagnostics. Follow us on Twitter and Facebook for daily updates!